The American College of Gastroenterology’s Annual Scientific Meeting and Postgraduate Course, ACG 2024, will be held in Philadelphia, PA from October 25-30, 2024. This prestigious event will cater to the educational needs and priorities of clinical GI practitioners, covering the latest advancements in clinical GI, hepatology, and endoscopy.

If you have not yet registered for this year’s meeting, we highly recommend doing so here. Attending will offer you the opportunity to advance your career, expand your professional network, earn CME credits, explore numerous posters featuring impactful clinical research, and gain the knowledge needed to improve patient care.

Highlighted below are key sessions at ACG 2024 focusing on Inflammatory Bowel Disease (IBD), such as optimal treatments for patients, dietary strategies for symptom management, monitoring therapy effectiveness, the most effective interventions for Crohn’s disease patients experiencing obstructive symptoms and more. These sessions are conveniently arranged in chronological order for your ease of access.

Monday October 28, 2024

Getting It Right the First Time: Choosing the Optimal Treatment for Your IBD Patient

  • Time: 11:30 am
  • Description: Recognize the role of network analysis in comparing IBD treatment options in the absence of head-to-head trials.

Clinical Updates in the Management of Hospitalized IBD Patients

  • Time: 4:45 pm
  • Improving Outcomes for the Hospitalized IBD Patient: Strategies for Optimizing Inpatient Care
    • Describe the initial management for hospitalized IBD patients including diagnostic work-up, supportive care recommendations, diet, and symptom control.
  • The Crohn’s Disease Patient Presenting With Obstructive Symptoms – What Is the Best Intervention?
    • Highlight indications for surgery versus medical optimization for the Crohn’s patient, including the role of corticosteroids, advanced therapies, endoscopic therapies, and inpatient supportive care regimens.
  • The Biologic-Experienced Ulcerative Colitis Patient – Continue or Cut?
    • Summarize the appropriate candidates and options for advanced therapy versus surgery for biologic-experienced IBD patients.

Bonus Session: Practical Guide for IBD Activity and Therapy Monitoring

  • We Just Started a New Treatment: When, What, and How for Disease Activity Monitoring
    • Summarize recommended strategies for disease activity assessments including diagnostic testing options, considerations of costs, and access to care.
  • How Often Should I Be Getting Blood Work? Guidance for Monitoring Lab Abnormalities With the Newer Advanced Therapies
    • Outline recommendations for monitoring the newer advanced therapies for IBD including sphingosine-1-receptor agonists, JAK inhibitors, and interleukin-antagonists, and address potential lab abnormalities.
  • When Do We Stop the Treatment? Recognizing and Managing Adverse Effects Associated With Advanced Therapies
    • Explain the adverse effects of the newer advanced therapies for IBD, and when to recommend discontinuing, pausing, or continuing therapy.

Bonus Session: Improving Health Equity in IBD

  • Current Disparities in IBD Care: How to Close the Gaps
    • Describe the literature on disparities in care in the IBD patient population including the financial toxicity of IBD care, with an emphasis on creating awareness and proposing solutions to help narrow the gaps.
  • IBD in the LGBTQIA+ Community
    • Highlight the specific needs of IBD patients who are part of the LGBTQIA+ community, with a focus on strategies for optimizing patient care.
  • Remote Control: IBD Care in Rural Communities
    • Summarize what is known and unknown for optimizing care for IBD patients who do not live near IBD centers and outline best practices for ensuring appropriate care.
Tuesday, October 29, 2024

How to Address Abdominal Pain

  • Time: 5:10 pm
  • Take Another Look – Beyond IBS
    • Describe how to identify and manage conditions which present similarly to irritable bowel syndrome, such as disaccharidase deficiencies, SIBO/IMO, cannabis use/abuse, gastropathies, and enteropathies.
  • The Role of Neuromodulators – When and How to Use Them
    • Explain the mechanisms of action of neuromodulators to treat specific symptoms including nausea, vomiting, abdominal pain, diarrhea, and constipation.
  • After the Visit – Resources to Offer Your Patients
    • Outline patient-focused adjunct resources, such as nutrition services, psychologist services (hypnosis, CBT), CAM, and clinical apps, for tracking symptoms and clinical management.
Wednesday, October 29, 2024

When Should We Use These Medications? Clinical Roundtable Discussion With the IBD Experts

  • Time: 11:00 am
  • Case: Newly Diagnosed Moderate UC in a Young Adult
    • Explain the clinical applications of the newer FDA-approved advanced therapies for ulcerative colitis.
  • Case: Severe UC in an Older Adult, Primary Non-Responder to Infliximab
    • Describe the best practices for management of older biologic-experienced IBD patients with active disease.
  • Case: Crohn’s Disease Flare in a Pregnant TNF-Experienced Patient on Ustekinumab
    • Summarize the approach to advanced therapy for the flaring pregnant IBD patient.

The ACG 2024 Annual Scientific Meeting and Postgraduate Course is set to showcase in-depth discussions on the latest advancements in GI care. This event guarantees to be both enlightening and engaging, offering attendees valuable insights and knowledge. We are thrilled to attend and eagerly anticipate your presence at the conference!

Sign up for alerts and stay informed on the latest published guidelines and stay tuned for our AACAP recap post the conference.

Copyright © 2024 Guideline Central, All Rights Reserved.